Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

NHS England

This public procurement record has 1 release in its history.

Award

06 Apr 2023 at 16:54

Award Notice
Summary of the contracting process

NHS England has awarded a Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals, with a total value of GBP 304,504,000. The procurement method was an Open procedure with a tender period ending on December 12, 2022. The contract period is from May 1, 2023, to April 30, 2025, offering opportunities for SMEs and large-scale suppliers in the pharmaceutical products sector, with the buying organisation located at 2nd Floor Rutland House, Runcorn, WA7 2ES, United Kingdom.

This tender by NHS England presents lucrative opportunities for suppliers in the pharmaceutical industry to compete for providing branded medicines nationally. Businesses, both SMEs and large-scale enterprises, specialising in pharmaceutical products, should consider engaging with NHS England in this procurement stage to explore potential growth opportunities and establish long-term partnerships for the outlined contract period.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

Notice Description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-f3419ee6-884e-4ba4-9f88-cdfcb350ba4e
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/4df14586-94d9-4b98-adbf-f5a321e30282
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£304,504,000 £100M-£1B
Lots Value
Not specified
Awards Value
£304,504,000 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
6 Apr 20233 years ago
Submission Deadline
12 Dec 2022Expired
Future Notice Date
Not specified
Award Date
6 Apr 20233 years ago
Contract Period
1 May 2023 - 30 Apr 2025 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
50
Supplier Names

Mercury Pharmaceuticals Ltd

Gerot Lannach UK Ltd

Bayer Plc

AVENTIS PHARMA LIMITED t-a Sanofi

Tillomed Laboratories ltd

Sandoz Ltd

Pfizer Ltd

Accord-UK Ltd

Otsuka Pharmaceuticals UK Limited

Morningside Pharmaeuticals

Astellas Pharma Ltd

Wockhardt UK Limited

Lupin Healthcare UK Ltd

Ipsen

Mylan

Neuraxpharm UK Ltd

Ridge Pharma

Ferring Pharmaceuticals Ltd

Drugsrus Ltd

medac Pharma LLP

Kent Pharma Ltd

Martindale Pharma

Janssen-Cilag Ltd

Day Lewis Medical Ltd

Zentiva Pharma UK Ltd

Teva UK Limited

Glenmark Pharmaceuticals Europe Ltd

Pharmasure Ltd

Xiromed

Recordati Rare Diseases UK Ltd

Aspire Pharma Ltd

Chiesi Limited

Selective Supplies Ltd

Napp Pharmaceuticals Ltd

Aspen Pharmacare UK Limited

Gedeon Richter UK Ltd

Nordic Pharma Ltd

Novartis Pharmaceuticals UK Limited

Synchrony

Norgine Pharmaceuticals Limited

Orifarm UK Ltd

Qdem Pharmaceuticals

Eli Lilly & Company Ltd

CST Pharma Limited

ROVI Biotech Ltd

Merck Serono Limited

Takeda UK Limited

Tetris Pharma Lts

Dexcel Pharma Ltd

Theramex HQ UK

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...